ANA Pollution (2.06.2026)
DERM on RheumNow PODCAST (January 2026)
2025 Rheumatology Year in Review
Depression and RA (3.8.2024)
Be Stills, My Heart
Sniffles & Arthritis (3.1.2024)
Fever of Unknown Origin: Not Always an Infection
It's a Sore Subject
An Expert Perspective on Polygenic Autoinflammatory Diseases Sponsored By Novartis Pharmaceuticals Corporation
Drs. Liebowitz and Mehta discuss the clinical features, early recognition, complications, and management transitions from childhood to adulthood for patients with polygenic autoinflammatory diseases.
Managing Monogenic Autoinflammatory Diseases- What Rheumatologists Need to Know – Sponsored by Novartis Pharmaceuticals Corporation
Drs. Liebowitz and Mehta review the diagnostic concepts, risk factors, pathophysiology, and management of monogenic autoinflammatory diseases.
StillsNow Podcast December 2023 – ACR23 Highlights
CBT or Naltrexone in Fibromyalgia (12.8.2023)
Therapeutic Options for VEXAS
Hemophagocytic Lymphohistiocytosis in Still's Disease
Treatment of VEXAS?
Hemophagocytic Lymphohistiocytosis in Still’s disease
Dr. Bella Mehta discusses abstract 1143, presented at the 2023 ACR Convergence meeting in San Diego, CA.